Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range.
Several epidemiologic and clinical studies suggest that patients coinfected with human immunodeficiency virus (HIV), the primary etiologic agent in AIDS, and other viruses, such as cytomegalovirus or human T-cell leukemia virus (HTLV), have a more severe clinical course than those infected with HIV alone. Cells infected with two viruses can, in some cases, give rise to phenotypically mixed virions with altered or broadened cell tropism and could therefore account for some of these findings. Such pseudotypes could alter the course of disease by infecting more tissues than are normally infected by HIV. We show here that HIV type 1 (HIV-1) efficiently incorporates the HTLV type I (HTLV-I) envelope glycoprotein and that both HIV-1 and HTLV-II accept other widely divergent envelope glycoproteins to form infectious pseudotype viruses whose cellular tropisms and relative abilities to be transmitted by cell-free virions or by cell contact are determined by the heterologous envelope. We also show that the mechanism by which virions incorporate heterologous envelope glycoproteins is independent of the presence of the homologous glycoprotein or heterologous gag proteins. These results may have important implications for the mechanism of HIV pathogenesis.
Landau
N R
NR
Department of Microbiology and Immunology, University of California, San Francisco.
Page
K A
KA
Littman
D R
DR
D000818:Animals; D002460:Cell Line; D002472:Cell Transformation, Viral; D002474:Cell-Free System; D005822:Genetic Vectors; D015497:HIV-1 / Q000235:genetics*; D006367:HeLa Cells / Q000502:physiology; D015368:Human T-lymphotropic virus 1 / Q000235:genetics*; D006801:Humans; D009052:Leukemia Virus, Murine / Q000235:genetics; D010957:Plasmids; D011995:Recombination, Genetic; D014162:Transfection; D014759:Viral Envelope Proteins / Q000235:genetics*
D014759:Viral Envelope Proteins